Chester County News and Community Website
PHILADELPHIA, PA & SAN FRANCISCO, CA — Dispatch Bio has released new preclinical data showing encouraging progress for its lead therapeutic program, DISP-10, a first-of-its-kind combination approach designed to make …
New Playbook for Solid Tumors? Dispatch Bio Unveils Promising Preclinical Results Read More
PHILADELPHIA, PA & SAN FRANCISCO, CA — Dispatch Bio has entered into a clinical supply and collaboration agreement with Bristol Myers Squibb (BMS) to advance a first-of-its-kind solid tumor program, …
Breakthrough Team-Up? New CAR T Partnership Targets 90% of Solid Tumors Read More
PHILADELPHIA, PA & SAN FRANCISCO, CA — Dispatch Bio announced that it will present new data on its investigational cancer therapy, DISP-10, at the upcoming Society for Immunotherapy of Cancer …
Dispatch Bio to Present Novel Cancer Therapy Data at 2025 Society for Immunotherapy of Cancer Meeting Read More
PHILADELPHIA, PA & SAN FRANCISCO, CA — Dispatch Bio has appointed Mauro Avanzi, M.D., Ph.D., as Chief Medical Officer, strengthening the company’s leadership team as it prepares to advance its …
Dispatch Bio Appoints Mauro Avanzi, M.D., Ph.D., as Chief Medical Officer Read More PHILADELPHIA, PA & SAN FRANCISCO, CA — Dispatch Bio emerged from stealth this past week with a mission as ambitious as it is urgent: to develop a universal treatment for …
Dispatch Bio Launches With $216M and Bold Mission to Tackle All Solid Tumors Read More